This inventor holds 1 USPTO granted patent. Top assignees: Cmg Pharmaceutical Co., Ltd., Handok Inc.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 6 
1 out of 5 Years Active: 2017
Title: Soongyu Choi: Innovator in Trk Inhibitors
Introduction
Soongyu Choi is a notable inventor based in Yongin, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel chemical compounds.
Latest Patents
Choi holds a patent for "Fused ring heteroaryl compounds and their use as Trk inhibitors." This patent discloses novel chemical compounds represented by Formula I or a pharmaceutically acceptable salt, solvate, polymorph, ester, tautomer, or prodrug thereof. The compounds can be utilized as inhibitors of Trk and are beneficial in treating pain, cancer, inflammation, neurodegenerative diseases, and certain infectious diseases.
Career Highlights
Throughout his career, Soongyu Choi has worked with various pharmaceutical companies, including Cmg Pharmaceutical Co., Ltd. and Handok Inc. His work has focused on innovative solutions in drug development.
Collaborations
Choi has collaborated with notable colleagues such as Moonsoo Kim and Chaewoon Lee, contributing to advancements in his field.
Conclusion
Soongyu Choi's work in developing Trk inhibitors showcases his commitment to innovation in pharmaceuticals. His contributions are paving the way for new treatments in various medical conditions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile